The placental effects of trisomy for human chromosome 21 orthologs in four mouse models of Down syndrome
Biology Open · 2025
DOI: 10.1242/bio.062296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, 2025. Verfasst von Taisuke Sato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Precision Health Research, Prenatal Genomics and Therapy Section, National Human Genome Research Institute, National Institutes of Health,…. Hauptthemen laut MEDLINE: Down Syndrome, Trisomy, Chromosomes, Human, Pair 21, Placenta. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NHGRI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Down syndrome (DS) is caused by trisomy for human chromosome 21 (Hsa21) and is associated with atypical neurodevelopment that begins prenatally. The developing human fetus receives nutritional support and gas exchange from the placenta, and normal placental function is essential for proper development. Placentas that sustain fetuses with trisomy 21 contain trisomic cells, but little is known about which Hsa21 genes are overexpressed in the placenta or their downstream molecular, cellular, and functional effects. Although access to human placentas is limited, mouse models of DS provide excellent in vivo systems for investigating the prenatal effects of trisomy. This study examined the placental transcriptome in four mouse models of DS: Dp(16)1/Yey, Ts65Dn, Ts66Yah, and Ts1Cje. Placental gene and protein expression analyses showed that trisomy increased the expression of App, Sod1, and Ifnar1 in Dp(16)1/Yey, Ts65Dn, and Ts66Yah; APP and SOD1 in Dp(16)1/Yey and Ts66Yah; and IFNAR1 in Ts66Yah. Despite modest overlap of trisomy-associated gene dysregulation among these four models, altered extracellular matrix pathways in all four models and upregulation of immune system pathways in Dp(16)1/Yey and Ts66Yah were identified. Altered redox homeostasis was observed for all four models, with Ts1Cje showing distinct changes in SOD activity and antioxidant capacity in comparison to the other three models. Immunofluorescence staining revealed region-specific upregulation of APP, SOD1, and IFNAR1 in Ts66Yah trisomic placentas. This work provides a foundation for understanding the effects of trisomy for Hsa21 orthologs on the mouse placenta and on prenatal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Precision Health Research, Prenatal Genomics and Therapy Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
- Columbia University Irving Medical Center, Division of Reproductive Endocrinology and Infertility, New York, NY 10019, USA.
ORCID-Profile: Laura L Baxter, Faycal Guedj, Diana W Bianchi
Förderung
- Intramural NIH HHS
- NHGRI NIH HHS
- NIH HHS
- Japan Society for the Promotion of Science
Zitieren
APA
Sato, T., Baxter, L. L., Adams, A. D., Bishop, L. A., Guedj, F., & Bianchi, D. W. (2025). The placental effects of trisomy for human chromosome 21 orthologs in four mouse models of Down syndrome. Biology Open. https://doi.org/10.1242/bio.062296
Vancouver
Sato T, Baxter LL, Adams AD, Bishop LA, Guedj F, Bianchi DW. The placental effects of trisomy for human chromosome 21 orthologs in four mouse models of Down syndrome. Biology Open. 2025. doi:10.1242/bio.062296
BibTeX
@article{Sato2025,
author = {Sato, Taisuke and Baxter, Laura L and Adams, April D and Bishop, Lauren A and Guedj, Faycal and Bianchi, Diana W},
title = {The placental effects of trisomy for human chromosome 21 orthologs in four mouse models of Down syndrome},
journal = {Biology Open},
year = {2025},
doi = {10.1242/bio.062296}
}
EUVIMED